retatrutide benefits clinical trials New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats New GLP-1 obesity drug, retatrutide,

2017a, b

A clinical series published in the Journal of Clinical Medicine found that patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) who received intermittent intravenous saline infusions over a 9-week period showed beneficial effects in managing symptoms of dysautonomia and postural orthostatic tachycardia syndrome (POTS)

Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats

Blood Sugar Balance Low blood sugar can trigger cravings for alcohol

Because of the subject matter, and the serious consequences of a political approach to problem-solving, a bipartisan approach in Congress is badly needed